Delivery Order SPE2DB24D2101-SPE2DB25FKPQE
- Not listed
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $13,069.86 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia Clickject 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- The Defense Logistics Agency has awarded a delivery order valued at $7,188.08 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a biologic immunosuppressant medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside procurement executed through the company's existing DLA contract...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $31,263.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, which is a child order under a larger indefinite delivery contract vehicle, was competitively awarded without set-aside designation on May 7, 2025, with an ultimate completion date of May 8, 2025. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $11,814.85 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and was awarded competitively without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $6,937.20 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price procurement with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $76,256.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued on a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This non-competitive delivery order, valued at $3,954.49 with firm fixed pricing, is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPQEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order is valued at $13,647.57 with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and was competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a prime vendor for military healthcare systems, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support Defense Department medical needs worldwide. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements, from routine generic medications to specialized biologics and medical devices supporting military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/16/25 |